Tracer Pharmaceuticals Availability and Distribution Trends Prior to and During the Covid-19 Pandemic: A Comparative Study

Figures & data

Figure 1 Line-item fill rate for tracer health program pharmaceuticals before and during COVID-19.

Figure 2 Line-item fill rate for tracer RDF pharmaceuticals before and during COVID-19.

Figure 3 Distribution trends for tracer health program commodities.

Figure 4 Distribution trends for tracer RDF commodities.

Table 1 Paired Sampled Statistics Before and During the COVID-19 Pandemic

		Mean (M)	N	Std. Deviation (SD)	Std. Error Mean
Pair 1	Prior to Covid-19 incidence	81,317	25	139,274	27,855
	After the Covid-19 pandemic	60,212	25	94,966	18,993

Table 2 Mean Differences (t-test) of Tracer Pharmaceuticals

		Paired Differences					t	df	Sig. (2-Tailed)
		Mean	Std. Deviation	Std. Error Mean	95% CI of the Difference
					Lower	Upper
Pair 1	Prior to Covid-19 incidence – After the Covid-19 pandemic	21,105	46,095	9219	2078	40,132	2.289	24	0.031